Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The benzodiazepine binding site on the GABA(A) receptor is a well-characterized extracellular allosteric pocket formed at specific alpha/gamma interfaces. Its occupation by drugs like diazepam enhances inhibitory neurotransmission through increased chloride conductance in response to endogenous GABA—a mechanism underlying many widely used sedative/anxiolytic medications today.
Positive allosteric modulation of GABA(A) receptors, increasing the frequency of chloride channel opening in response to GABA.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GABA(A) Receptor Benzodiazepine Binding Site (BZ Binding Site).